Parameter Parameter Parameter AFRS Suspect AFRS FBS p-value
Laboratory reports Laboratory reports
GM test positive GM test positive n, % n, % 6 (20.7%)* 14 (20.3%)** 14 (2.6%) .000
Eosinophils Increased (n, %) Increased (n, %) Increased (n, %) 9 (31.0)** 28 (40.6)** 8 (1.5)
Percentage (Mean,SD) Percentage (Mean,SD) Percentage (Mean,SD) 6.7±6.0** 7.0±5.2** 2.5±1.9 1.36611E-14
Basophils Increased (n, %) Increased (n, %) Increased (n, %) 4 (13.8)* 15 (21.7)** 20 (3.8)
Percentage (Mean,SD) Percentage (Mean,SD) Percentage (Mean,SD) 0.8±1.5* 0.7±0.4** 0.5±0.4 3.76161E-4
Relapse frequency Relapse frequency Maximum Maximum 5 3 2
Mean,SD Mean,SD 0.5±0.8* 0.7±1.0** 0.1±0.3 2.965E-7
Total serum IgE(IU/ml, Mean, SD) Total serum IgE(IU/ml, Mean, SD) Total serum IgE(IU/ml, Mean, SD) Total serum IgE(IU/ml, Mean, SD) 394.6±167.5** 346.3±183.8** 81.1±93.6 1.30281E-8
Clinical complication Clinical complication Clinical complication Clinical complication Clinical complication Clinical complication Clinical complication Clinical complication
Olfactory dysfunction n (%) Olfactory dysfunction n (%) Olfactory dysfunction n (%) Olfactory dysfunction n (%) 15 (51.7)** 40 (58.0)** 83 (15.6) .000
Asthma Asthma n (%) n (%) 4 (13.8)** 7 (10.1)** 3 (0.6) .000
Allergic rhinitis Allergic rhinitis n (%) n (%) 16 (55.2)** 27 (39.1)** 33 (6.2) .000